Ohr Pharmaceutical Inc Bonus & Incentive Agreements
7 Contracts & Agreements
- Amendment No. 1 to NeuBase Therapeutics, Inc. 2019 Stock Incentive Plan (Filed With SEC on July 31, 2023)
- Form of Option Agreement under NeuBase Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on March 8, 2019)
- NeuBase Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on March 8, 2019)
- Retention Bonus Agreement, by and between Ohr Pharmaceutical, Inc. and Dr. Jason Slakter (Filed With SEC on January 3, 2019)
- Amendment to The 2014 Stock Incentive Plan (Filed With SEC on December 14, 2015)
- 2014 Stock Incentive Plan, as amended (Filed With SEC on March 13, 2015)
- 2014 Stock Incentive Plan (Filed With SEC on April 14, 2014)
